Cargando…

A Single Arm Clinical Study on the Effects of Continuous Erythropoietin Receptor Activator Treatment in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia

Erythropoiesis-stimulating agents improve the NYHA functional class and decrease the hospital readmission rates for heart failure; however, little is known about the influence of continuous erythropoietin receptor activator (CERA) on the heart. Therefore, a prospective study was conducted to investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sezai, Akira, Sekino, Hisakuni, Taoka, Makoto, Osaka, Shunji, Tanaka, Masashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046271/ https://www.ncbi.nlm.nih.gov/pubmed/36979925 http://dx.doi.org/10.3390/biomedicines11030946

Ejemplares similares

A Comparative Study to Investigate the Effects of Bisoprolol in Patients with Chronic Heart Failure and Hypertension When Switched from Tablets to Transdermal Patches
por: Sezai, Akira, et al.
Publicado: (2023)

Canagliflozin for Japanese patients with chronic heart failure and type II diabetes
por: Sezai, Akira, et al.
Publicado: (2019)

Changeover Trial of Febuxostat and Topiroxostat for Hyperuricemia with Cardiovascular Disease: Sub-Analysis for Chronic Kidney Disease (TROFEO CKD Trial)
por: Sezai, Akira, et al.
Publicado: (2019)

A Comparative Prospective Observational Study on the Use of Direct Oral Anticoagulants after Cardiac Surgery for the Management of Atrial Fibrillation
por: Sezai, Akira, et al.
Publicado: (2020)

Efficacy of continuous erythropoietin receptor activator for end-stage renal disease patients with renal anemia before and after peritoneal dialysis initiation
por: Fujimoto, Daisuke, et al.
Publicado: (2020)

Comparing the Effects of Canagliflozin vs. Glimepiride by Body Mass Index in Patients with Type 2 Diabetes and Chronic Heart Failure: A Subanalysis of the CANDLE Trial
por: Sezai, Akira, et al.
Publicado: (2022)

Iatrogenic acute aortic dissection caused by intervention for spontaneous coronary artery dissection: a surgical case report
por: Hayashi, Yuki, et al.
Publicado: (2020)

Does Epicardial Adipose Tissue Influence Postoperative Atrial Fibrillation?
por: Kogo, Hiroko, et al.
Publicado: (2018)

Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator)
por: Panchapakesan, Usha, et al.
Publicado: (2007)

Cost-effectiveness of continuous erythropoietin receptor activator in anemia
por: Schmid, Holger
Publicado: (2014)

Successful Introduction of Peritoneal Dialysis in an End-stage Renal Failure Patient with Idiopathic Aplastic Anemia
por: Suzuki, Yasuhiro, et al.
Publicado: (2020)

Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin
por: Ruifrok, Willem-Peter T., et al.
Publicado: (2010)

Siwu Granules and Erythropoietin Synergistically Ameliorated Anemia in Adenine-Induced Chronic Renal Failure Rats
por: Wu, Yansheng, et al.
Publicado: (2019)

The Predictive Parameters of Erythropoietin Hyporesponsiveness in Patients on Continuous Ambulatory Peritoneal Dialysis
por: Kim, Jeong Ki, et al.
Publicado: (2001)

Serum erythropoietin level predicts the prognosis of chronic heart failure with or without anemia
por: GUO, LING, et al.
Publicado: (2013)

Efficacy and safety of recombinant human erythropoietin (Hema-Plus(®)) for management of anemia in Thai patients on peritoneal dialysis
por: Chuengsaman, Piyatida, et al.
Publicado: (2021)

Efficacy & safety of continuous erythropoietin receptor activator (CERA) in treating renal anaemia in diabetic patients with chronic kidney disease not on dialysis
por: Vankar, Sameer G., et al.
Publicado: (2014)

Correction of Anemia with Continuous Erythropoietin Receptor Activator in Korean Patients on Long-Term Hemodialysis
por: Oh, Jieun, et al.
Publicado: (2014)

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)

Continuous ambulatory peritoneal dialysis: experience with 22 unselected patients with renal failure.
por: Finkelstein, F. O., et al.
Publicado: (1981)

A prospective observational study of early intervention with erythropoietin therapy and renal survival in non-dialysis chronic kidney disease patients with anemia: JET-STREAM Study
por: Akizawa, Tadao, et al.
Publicado: (2016)

Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice
por: Pan, Xiaoqing, et al.
Publicado: (2011)

Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients
por: Nasri, Hamid
Publicado: (2014)

Lipocalin-2, Soluble Transferrin Receptor, and Erythropoietin in Anemia During Mild Renal Dysfunction
por: Nahm, Chung Hyun, et al.
Publicado: (2023)

Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis
por: Akizawa, Tadao, et al.
Publicado: (2021)

Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction
por: Debeljak, Nataša, et al.
Publicado: (2014)

Treatment of Anemia in Kidney Disease: Beyond Erythropoietin
por: Wish, Jay B.
Publicado: (2021)

Effect of membrane dialysis and filtration-sterilization on erythropoietin activity.
por: Gallicchio, V. S., et al.
Publicado: (1981)

Erythropoietin and renal protection
por: Baradaran, Azar, et al.
Publicado: (2013)

Erythropoietin in the intensive care unit: beyond treatment of anemia
por: Patel, Nimesh SA, et al.
Publicado: (2011)

Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology
por: Gowanlock, Zachary, et al.
Publicado: (2016)

Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin
por: Hanna, Ramy M., et al.
Publicado: (2020)

Erythropoietin in bone homeostasis—Implications for efficacious anemia therapy
por: Lappin, Katrina M., et al.
Publicado: (2021)

Serum Erythropoietin level in anemia of elderly with unclear etiology
por: Seong, Ju Yong, et al.
Publicado: (2023)

Erythropoietin therapy improves endothelial function in patients with non-dialysis chronic kidney disease and anemia (EARNEST-CKD): A clinical study
por: Lim, Jina, et al.
Publicado: (2021)

Factors Contributing to Erythropoietin Hyporesponsiveness in Patients on Long-Term Continuous Ambulatory Peritoneal Dialysis: A Cross-Sectional Study
por: Hara, Takashi, et al.
Publicado: (2015)

Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study
por: Zheng, Xiaomeng, et al.
Publicado: (2023)

Psychiatric issues in renal failure and dialysis
por: De Sousa, A.
Publicado: (2008)

Safety and Efficacy of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors vs. Erythropoietin-Stimulating Agents in Treating Anemia in Renal Patients (With or Without Dialysis): A Meta-Analysis and Systematic Review
por: Damarlapally, Nanush, et al.
Publicado: (2023)

Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis
por: Provenzano, Robert, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e001a9ol6ngr68g8636njj4bdf